Gill J S, Rose C, Pereira B J G, Tonelli M
Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
Kidney Int. 2007 Mar;71(5):442-7. doi: 10.1038/sj.ki.5002072. Epub 2007 Jan 17.
Analyses describing outcomes of kidney transplantation usually exclude the survival of wait-listed patients and dialysis patients with failed kidney transplants, and thus reflect only a portion of the typical transplant process. We determined death rates during the continuum of wait-listing, transplantation, and after allograft failure among adult end-stage renal disease patients in the United States between 1995 and 2003. Before transplantation, death rates increased with longer waiting times. Death rates were lowest during the period of allograft function and highest after allograft failure. Patients were at particularly high risk during periods of transition between dialysis and transplantation (death rates during the peri-transplant period and during the re-initiation of dialysis after transplant failure were 8.2/100 patient-years (95% confidence interval (CI) 7.7, 8.8) and 17.9/100 patient-years (95% CI 15.7, 20.3), respectively compared to 6.4/100 patient-years (95% CI 6.25, 6.51) during the period of wait-listing. Diabetic patients and older patients were at increased risk at all time points. The most common known cause of death in all age subgroups was cardiovascular disease. The proportion of death owing to sepsis was greatest after allograft failure (16.8% of all deaths were due to sepsis compared to 14.0% during wait-listing, and 12.7% during the period of allograft function). Consideration of the entire transplant experience as a whole should help to focus patient care on periods of particularly high risk, and emphasizes opportunities to improve outcomes by strategies aimed at preventing death owing to cardiovascular and infectious causes.
描述肾移植结果的分析通常不包括等待名单上患者以及肾移植失败后透析患者的生存情况,因此仅反映了典型移植过程的一部分。我们确定了1995年至2003年间美国成年终末期肾病患者在等待名单、移植以及移植失败后的整个过程中的死亡率。移植前,死亡率随等待时间延长而增加。移植肾功能期死亡率最低,移植失败后最高。在透析和移植的过渡期患者风险尤其高(移植围手术期和移植失败后重新开始透析期间的死亡率分别为8.2/100患者年(95%置信区间(CI)7.7, 8.8)和17.9/100患者年(95%CI 15.7, 20.3),相比之下等待名单期间为6.4/100患者年(95%CI 6.25, 6.51))。糖尿病患者和老年患者在所有时间点风险均增加。所有年龄亚组中最常见的已知死亡原因是心血管疾病。移植失败后因败血症导致的死亡比例最大(所有死亡中有16.8%归因于败血症,相比之下等待名单期间为14.0%,移植肾功能期为12.7%)。将整个移植经历作为一个整体来考虑应有助于将患者护理重点放在风险特别高的时期,并强调通过旨在预防心血管和感染性原因导致死亡的策略来改善结果的机会。